Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 125
2021 250
2022 251
2023 135
2024 83
2025 46
2026 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

819 results

Results by year

Filters applied: . Clear all
Page 1
Ivermectin for preventing and treating COVID-19.
Popp M, Reis S, Schießer S, Hausinger RI, Stegemann M, Metzendorf MI, Kranke P, Meybohm P, Skoetz N, Weibel S. Popp M, et al. Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD015017. doi: 10.1002/14651858.CD015017.pub3. Cochrane Database Syst Rev. 2022. PMID: 35726131 Free PMC article.
BACKGROUND: Ivermectin, an antiparasitic agent, inhibits the replication of viruses in vitro. The molecular hypothesis of ivermectin's antiviral mode of action suggests an inhibitory effect on severe acute respiratory syndrome c …
BACKGROUND: Ivermectin, an antiparasitic agent, inhibits the replication of viruses in vitro. The molecular hypothesis of ivermect …
Ivermectin in COVID-19: What do we know?
Pandey S, Pathak SK, Pandey A, Salunke AA, Chawla J, Sharma A, Sharma S, Thivari P, Ratna HVK. Pandey S, et al. Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1921-1922. doi: 10.1016/j.dsx.2020.09.027. Epub 2020 Sep 28. Diabetes Metab Syndr. 2020. PMID: 33032231 Free PMC article. Review. No abstract available.
Ivermectin in COVID-19 Management: What is the Current Evidence?
Eerike M, Raj GM, Priyadarshini R, Ravi G, Bisoi D, Konda VGR. Eerike M, et al. Infect Disord Drug Targets. 2022;22(4):e190122200367. doi: 10.2174/1871526522666220119114035. Infect Disord Drug Targets. 2022. PMID: 35043770 Review.
Antiviral activity is due to the inhibition of nuclear cargo importin (IMP) protein. The anti-SARS CoV-2 activity through in vitro study was first reported by an Australian team. Later, many studies were conducted, and most of the study results were available …
Antiviral activity is due to the inhibition of nuclear cargo importin (IMP) protein. The anti-SARS CoV-2 activity throu …
Ivermectin for preventing and treating COVID-19.
Popp M, Stegemann M, Metzendorf MI, Gould S, Kranke P, Meybohm P, Skoetz N, Weibel S. Popp M, et al. Cochrane Database Syst Rev. 2021 Jul 28;7(7):CD015017. doi: 10.1002/14651858.CD015017.pub2. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 Jun 21;6:CD015017. doi: 10.1002/14651858.CD015017.pub3. PMID: 34318930 Free PMC article. Updated.
The molecular hypothesis of ivermectin's antiviral mode of action suggests an inhibitory effect on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in the early stages of infectio …
The molecular hypothesis of ivermectin's antiviral mode of action suggests an inhibitory effect on severe acute …
Ivermectin for COVID-19: The 2022 Update.
Manu P. Manu P. Am J Ther. 2022 Nov-Dec 01;29(6):e647-e648. doi: 10.1097/MJT.0000000000001577. Am J Ther. 2022. PMID: 36608065 No abstract available.
Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities.
Wehbe Z, Wehbe M, Iratni R, Pintus G, Zaraket H, Yassine HM, Eid AH. Wehbe Z, et al. Front Immunol. 2021 Mar 30;12:663586. doi: 10.3389/fimmu.2021.663586. eCollection 2021. Front Immunol. 2021. PMID: 33859652 Free PMC article. Review.
As of January 2021, SARS-CoV-2 has killed over 2 million individuals across the world. As such, there is an urgent need for vaccines and therapeutics to reduce the burden of COVID-19. ...IVM later exerted antiviral activity against various virus …
As of January 2021, SARS-CoV-2 has killed over 2 million individuals across the world. As such, there is an urgent need …
Repurposing the drug, ivermectin, in COVID-19: toxicological points of view.
Shirazi FM, Mirzaei R, Nakhaee S, Nejatian A, Ghafari S, Mehrpour O. Shirazi FM, et al. Eur J Med Res. 2022 Feb 5;27(1):21. doi: 10.1186/s40001-022-00645-8. Eur J Med Res. 2022. PMID: 35123559 Free PMC article. Review.
None of these agents have been effective except for steroids and, to a lesser degree, tocilizumab. Ivermectin has been one of the suggested repurposed medications which exhibit an in vitro inhibitory activity on SARS-CoV-2 replication. The most recomme …
None of these agents have been effective except for steroids and, to a lesser degree, tocilizumab. Ivermectin has been one of the sug …
Ivermectin and the Integrity of Healthcare Evidence During COVID-19.
O'Mathúna DP. O'Mathúna DP. Front Public Health. 2022 Mar 1;10:788972. doi: 10.3389/fpubh.2022.788972. eCollection 2022. Front Public Health. 2022. PMID: 35299698 Free PMC article. Review.
The COVID-19 pandemic has been characterized by a lack of clear evidence to guide healthcare professionals, the public and policymakers. ...This drug is alleged to be effective in treating COVID-19, with various studies and systematic reviews finding s …
The COVID-19 pandemic has been characterized by a lack of clear evidence to guide healthcare professionals, the public and pol …
Ivermectin as a possible treatment for COVID-19: a review of the 2022 protocols.
Marques LLM, Beneti SC, Pinzon C, Cardoso FAR. Marques LLM, et al. Braz J Biol. 2022 May 20;84:e258325. doi: 10.1590/1519-6984.258325. eCollection 2022. Braz J Biol. 2022. PMID: 35584459 Free article. Review.
The in vitro results of ivermectin for reducing SARS-CoV-2 viral load are promising and show that Ivermectin kills SARS-CoV-2 within 48 hours. ...However, controlled and randomized studies are needed to prove its effectivene …
The in vitro results of ivermectin for reducing SARS-CoV-2 viral load are promising and show that Ivermectin …
Ivermectin's Role in the Prevention of COVID-19: A Systematic Review and Meta-Analysis.
Hu GY, Liang CA, Lin PC, Lin CY. Hu GY, et al. J Clin Pharmacol. 2023 Mar;63(3):288-297. doi: 10.1002/jcph.2178. Epub 2022 Dec 10. J Clin Pharmacol. 2023. PMID: 36399336
Randomized controlled trials (RCTs) and cohort studies investigating ivermectin for coronavirus disease 2019 (COVID-19) prevention were included. Data were pooled using a random-effects model, and subgroups were analyzed by study type and the pre- or p …
Randomized controlled trials (RCTs) and cohort studies investigating ivermectin for coronavirus disease 2019 (COVID- …
819 results